fbpx

Xstrahl in Action: SARRP Assists in EPR-Mediated Tumor Targeting

[:us]In the study, EPR-Mediated Tumor Targeting using Ultrasmall-hybrid Nanoparticles: From Animal to Human with Theranostic AGuIX Nanoparticles, SARRP was used to experience the therapeutic action of enhanced permeability and retention (EPR)-mediated tumor targeting using AGuIX® NPs at low dose specifically when accumulated and activated at the tumor site.

See more below, or the full study here.

[:]

Contact Us

Find out more about why Xstrahl will work tirelessly for you

Explore Related Posts